Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products
Authors:
- Myra CoppageMCMyra Coppage
- Marc BakerMBMarc Baker
- Lawrence FialkowLFLawrence Fialkow
- Danielle MeehanDMDanielle Meehan
- Kelly GettingsKGKelly Gettings
- Leway ChenLCLeway Chen
- H. Todd MasseyHMH. Todd Massey
- Neil BlumbergNBNeil Blumberg
- 1 June 2009
- journal article
- Published by Elsevier in Human Immunology
- Vol. 70 (6) , 413-416
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injuryBlood, 2006
- Sensitization Following LVAD Implantation Using Leucodepleted Blood Is Not Due to HLA AntibodiesAmerican Journal of Transplantation, 2006
- Lack of Sensitization and Equivalent Post-transplant Outcomes With the Novacor Left Ventricular Assist DeviceThe Journal of Heart and Lung Transplantation, 2005
- Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubtTransfusion, 2005
- Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference*Transfusion Medicine Reviews, 2001
- IMPROVED FLOW CYTOMETRIC DETECTION OF HLA ALLOANTIBODIES USING PRONASETransplantation, 2001
- Interaction of Platelet Fc and Complement Receptors with Circulating Immune Complexes Involving the AB0 SystemVox Sanguinis, 1996
- Leukodepleted‐ABO‐identical blood components in the treatment of hematologic malignancies: A cost analysisAmerican Journal of Hematology, 1995
- A possible survival advantage in adults with acute leukemia receiving ABO‐identical platelet transfusionsAmerican Journal of Hematology, 1994
- COMPARISON OF IMMUNOGENICITY OF FRESH AND STORED BLOOD A STUDY IN RHESUS MONKEYSTransplantation, 1982